Contract

CLI-OJEU-50937 Ultra-High Resolution Human Leukocyte Antigen (HLA) Typing for the Welsh Bone Marrow Donor Registry

  • NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

F03: Contract award notice

Notice identifier: 2023/S 000-021865

Procurement identifier (OCID): ocds-h6vhtk-035688

Published 27 July 2023, 3:49pm



Section one: Contracting authority

one.1) Name and addresses

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

Alder House, Alder Court, St Asaph Business Park

St Asaph

LL17 0JL

Email

Joanne.liddle@wales.nhs.uk

Telephone

+44 1443848585

Country

United Kingdom

NUTS code

UK - United Kingdom

Internet address(es)

Main address

http://nwssp.nhs.wales/ourservices/procurement-services/

Buyer's address

https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

CLI-OJEU-50937 Ultra-High Resolution Human Leukocyte Antigen (HLA) Typing for the Welsh Bone Marrow Donor Registry

Reference number

CLI-OJEU-50937

two.1.2) Main CPV code

  • 85121200 - Medical specialist services

two.1.3) Type of contract

Services

two.1.4) Short description

NWSSP Procurement Services, hosted by Velindre University NHS Trust, and the Welsh Bone Marrow Donor Registry (WBMDR), part of Welsh Blood Service, are seeking to appoint a suitably qualified contractor to perform Ultra-High Resolution HLA Typing.

The Welsh Bone Marrow Donor Registry (WBMDR) recruits volunteer donors via blood sample and cheek swab (buccal swab) to support stem cell transplantation. The WBMDR has different typing and testing requirements depending on sample type:

For whole blood samples: We require Ultra High Resolution (UHR) HLA-A, B, C, DRB1, DQA1, DQB1, DPA1, DPB1 and DRB3/4/5 HLA typing. The provision of CCR5 testing from whole blood samples is desirable.

For cheek swab samples: We require Ultra High Resolution (UHR) HLA-A, B, C, DRB1, DQA1, DQB1, DPA1, DPB1 and DRB3/4/5 HLA typing as well as ABO/Rh and CMV testing.

Please refer to the Specification within the Invitation to Tender document.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Lowest offer: £843,950 / Highest offer: £3,770,000 taken into consideration

two.2) Description

two.2.2) Additional CPV code(s)

  • 85111810 - Blood analysis services

two.2.3) Place of performance

NUTS codes
  • UKL - Wales

two.2.4) Description of the procurement

NHS Wales Shared Services Partnership, Procurement Services hosted by Velindre University NHS Trust is looking to award a contract for Ultra-High Resolution Human Leukocyte Antigen (HLA) Typing for the Welsh Bone Marrow Donor Registry (a division of Welsh Blood Service) by inviting Bidders to tender for this ITT.

The WBMDR oversees the recruitment of unrelated bone marrow volunteer donors and has an agreed target of recruiting 4000 new donors to the WBMDR stem cell donor panel each year.

Bidders must be able to deliver the HLA types of at least 4000 stem cell donors per annum at ultra-high resolution typing level for HLA-A, B, C, DRB1, DQB1 and DPB1 using next generation sequencing approach. Bidders must be able to deliver the HLA types of at least 4,000 stem cell donors per annum at allele level typing level for HLA-A, B, C, DRB1, DQB1 and DPB1 using a next generation sequencing approach (NGS).

Please refer to the Specification found at Appendix A of the ITT document for full information.

The contract will be for an initial period of three (3) years with the option to extend for a further two (2) years (maximum five year contract).

two.2.5) Award criteria

Quality criterion - Name: Core Requirements / Weighting: 20

Quality criterion - Name: HLA Result Reporting / Weighting: 10

Quality criterion - Name: Novel HLA Alleles / Weighting: 5

Quality criterion - Name: Timescales/Key Performance indicators / Weighting: 5

Quality criterion - Name: Service Levels & Performance / Weighting: 10

Quality criterion - Name: Reporting of Results / Weighting: 10

Price - Weighting: 40

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.1) Previous publication concerning this procedure

Notice number: 2023/S 000-002312


Section five. Award of contract

Contract No

CLI-OJEU-50937

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

1 July 2023

five.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received from SMEs: 2

Number of tenders received from tenderers from other EU Member States: 0

Number of tenders received from tenderers from non-EU Member States: 2

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

Histogenetics

300 Executive Blvd

Ossining/NY

10562

Telephone

+44 00000000000

Fax

+44 00000000000

Country

United States

NUTS code
  • US - United States
The contractor is an SME

Yes

five.2.4) Information on value of contract/lot (excluding VAT)

Total value of the contract/lot: £843,950


Section six. Complementary information

six.3) Additional information

(WA Ref:133598)

six.4) Procedures for review

six.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL

Telephone

+44 2079477501

Country

United Kingdom